Cargando…
PTPN18 Serves as a Potential Oncogene for Glioblastoma by Enhancing Immune Suppression
Glioblastoma is characterized as one of the deadliest cancers in humans. The survival time is not improved by standard treatment. Although immunotherapy has revolutionized cancer treatment, the current therapy targets for glioblastoma patients are not satisfied. We systematically analyzed the expres...
Autores principales: | Wang, Tao, Yu, Yang, Ba, Xinlei, Zhang, Xiaonan, Zhang, Na, Wang, Guowen, Bai, Bin, Li, Tong, Zhao, Jiahui, Zhao, Yanjiao, Wang, Bing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950791/ https://www.ncbi.nlm.nih.gov/pubmed/36846716 http://dx.doi.org/10.1155/2023/2994316 |
Ejemplares similares
-
Nuclear import of PTPN18 inhibits breast cancer metastasis mediated by MVP and importin β2
por: Wang, Tao, et al.
Publicado: (2022) -
The Tyrosine Phosphatase Activity of PTPN22 Is Involved in T Cell Development via the Regulation of TCR Expression
por: Bai, Bin, et al.
Publicado: (2023) -
Pan-cancer analyses of classical protein tyrosine phosphatases and phosphatase-targeted therapy in cancer
por: Wang, Tao, et al.
Publicado: (2022) -
Single-cell and bulk sequencing analyses reveal the immune suppressive role of PTPN6 in glioblastoma
por: Zhang, Xiaonan, et al.
Publicado: (2023) -
High Expression of PTPN3 Predicts Progression and Unfavorable Prognosis of Glioblastoma
por: Wang, Yu, et al.
Publicado: (2018)